The Emotional and Psychological Effects of Pediatric Movement Disorders on Families: A Concise Overview
-
By
-
Hanin AlGethami
-
June 5, 2026
By
Hanin AlGethami
June 5, 2026
by Hanin AlGethami
June 5, 2026
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026